EGLN2 and familial pancreatic carcinoma: [30]. In pancreatic cancer, Su et al. recently reported that PHD3 overexpression mediated tumor cell growth and invasion [26]. Overexpression of PHD1 was shown by Erez et al. to inhibit tumor growth [31].